Laman UtamaTMO • NYSE
add
Thermo Fisher Scientific Inc
$479.46
Selepas Waktu Dagangan:(0.00%)0.00
$479.46
Tutup: 12 Sep, 6:17:31 PTG GMT-4 · USD · NYSE · Penafian
Tutup sebelumnya
$491.37
Julat hari
$479.46 - $491.26
Julat tahun
$385.46 - $623.77
Permodalan pasaran
181.05B USD
Bilangan Purata
1.83J
Nisbah P/E
27.75
Hasil dividen
0.36%
Pertukaran utama
NYSE
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 10.86B | 2.98% |
Perbelanjaan pengendalian | 2.48B | -1.47% |
Pendapatan bersih | 1.62B | 4.46% |
Margin untung bersih | 14.90 | 1.43% |
Pendapatan bagi setiap syer | 5.36 | -0.19% |
EBITDA | 2.62B | -0.04% |
Kadar cukai berkesan | 5.38% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 6.39B | -27.58% |
Jumlah aset | 101.23B | 2.78% |
Jumlah liabiliti | 50.63B | -0.66% |
Jumlah ekuiti | 50.60B | — |
Syer tertunggak | 377.61J | — |
Harga kepada buku | 3.67 | — |
Pulangan pada aset | 4.84% | — |
Pulangan pada modal | 5.71% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 1.62B | 4.46% |
Tunai daripada operasi | 1.40B | -28.62% |
Tunai daripada pelaburan | -288.00J | -13.83% |
Tunai daripada pembiayaan | -991.00J | -761.74% |
Perubahan bersih dalam tunai | 431.00J | -72.69% |
Aliran tunai bebas | 736.12J | -44.08% |
Perihal
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation, Alfa Aesar, Affymetrix, FEI Company, BD Advanced Bioprocessing, and PPD.
It ranked 104th on the Fortune 500 list based on its 2024 annual revenue of $42.879 billion.
Thermo Fisher announced a $2 billion investment over four years in the U.S., including $1.5 billion for expanding manufacturing capacity and $500 million for R&D investment. This initiative aims to bolster domestic biotech manufacturing, create high-paying jobs, and reinforce the U.S. healthcare supply chain. Wikipedia
Diasaskan
1956
Ibu pejabat
Tapak web
Pekerja
125,000
